In this podcast, Chandler Howell, PharmD, speaks about the guideline-recommended first and second-line treatment options for type 2 diabetes, the pharmacist involvement in the care of people with diabetes, and gaps that exist in access to medication for people with fewer financial resources. He also presented on this topic at ADCES 2021.
In this podcast, Maura Jones, PharmD, BCPS, discusses clinical practice guidelines and various medication regimens for managing cardiovascular disease risks in patients with diabetes. This was a topic she recently presented on at ADCES21.
Caroline Trapp, DNP, ANP-BC, CDCES, on Achieving Remission of Type 2 Diabetes Through Lifestyle Medicine
In this podcast, Caroline Trapp, DNP, ANP-BC, CDCES, talks about ways to achieve partial and full remission of type 2 diabetes and how certified diabetes care and education specialists can identify the type and intensity of lifestyle modifications required for significant metabolic improvements and remission.
In this podcast, Lawrence Fisher, PhD, discusses his strategies for managing patients with diabetes who have diabetes distress, a topic he recently presented about at ADCES21.
In this podcast, Sri Banerjee, MD, PhD, MPH, MAS, speaks about the effect of smoking status on the association between diabetes and cardiovascular mortality, including how social factors impact tobacco use, how smoking cessation can decrease mortality from diabetes, and how diabetes can interact with other risk factors to affect cardiovascular health. He presented a poster abstract on this topic at the ADCES21 annual conference.
In this podcast, Dominick J. Angiolillo, MD, PhD, provides insight into a new analysis of the TWILIGHT Trial that he and his colleagues performed among high-risk patients with diabetes.
James Matera, DO, explains the interaction between diabetes, cardiovascular disease, and kidney disease, and how the presence of one or more of these conditions can complicate treatment outcomes.
In this podcast, Ralph Brindis, MD, MPH, interviews Laurence Sperling, MD, about treating patients with cardiovascular disease and diabetes—with a special focus on how to choose the appropriate novel therapy and how to initiate the therapy.
Stephanie Chung, MBBS, from the National Institutes of Health, discusses her latest paper about managing diabetes in patients of African descent—a particularly high-risk group.